TOG Review (RCOG Journal)

MRCOG Part 2

Subfertility and Reproductive Medicine

Fertility on ice

Key Statistics

  • >80% — Overall survival, childhood/adolescent cancer
  • 30% / 18% — Male survivors: Azoospermia / oligospermia
  • ≥10 Gy — Ovarian irradiation → POI risk

Don't-miss facts

  1. Ovarian/testicular tissue cryopreservation are the only FP options for prepubertal patients (girls/boys respectively) – oocyte/embryo freezing needs postpubertal ovarian stimulation

  2. Avoid OTC autotransplantation in leukaemia – high risk of reintroducing malignancy via contaminated ovarian tissue

  3. Oocyte vitrification reclassified non-experimental by ASRM/ESHRE in 2013; TTC and IVM remain experimental

  4. Ovarian irradiation ≥10 Gy → premature ovarian insufficiency; alkylating agents (cyclophosphamide, busulfan, chlorambucil) carry highest gonadotoxic risk

  5. Edinburgh criteria for OTC: age <35y, realistic 5-year survival, >50% POI risk, informed consent, negative HIV/syphilis/hepatitis B, not pregnant/no children

  6. GnRH agonists during chemo: benefit shown only in adult breast cancer; not recommended in other cancers (draft ESHRE) and ineffective prepubertally

  7. Cancer patients undergoing oocyte vitrification have worse outcomes than elective FP patients: live birth 40% vs 70%

  8. Survivors are ~38% less likely to achieve pregnancy than the general population – ensure timely fertility counselling

FP options by pubertal status

Prepubertal girl: ovarian tissue cryopreservation, ovarian transposition

Postpubertal girl: oocyte/embryo cryopreservation, OTC, IVM (experimental)

Prepubertal boy: testicular tissue cryopreservation (experimental, no live births) Postpubertal boy: sperm cryopreservation

Abbreviation Key

  • FP — fertility preservation
  • HSCT — haematopoietic stem cell transplant
  • AMH — anti-müllerian hormone
  • ICSI — intracytoplasmic sperm injection
  • OTC — ovarian tissue cryopreservation
  • hCG — human chorionic gonadotrophin
  • TTC — testicular tissue cryopreservation
  • GV — germinal vesicle (immature oocyte stage)
  • IVM — in vitro maturation
  • MII — metaphase II (mature oocyte stage)
  • OHSS — ovarian hyperstimulation syndrome
  • ASRM — American Society of Reproductive Medicine
  • POI — premature ovarian insufficiency
  • ESHRE — European Society of Human Reproduction and Embryology
  • GnRH — gonadotrophin-releasing hormone
  • ASCO — American Society of Clinical Oncology

Source: Hartigan L, Glover LE, Wingfield M. Fertility on ice: an overview of fertility preservation for children and adolescents with cancer. The Obstetrician & Gynaecologist 2021;23:170–176. doi:10.1111/tog.12753

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free